Arthritis cannabidiol - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 1961

<< First< Prev

Page of 99

Next >Last >>

Select item 77005281.

Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action

Jakub Mlost, Marta Bryk, Katarzyna Starowicz

Int J Mol Sci. 2020 Nov; 21(22): 8870. Published online 2020 Nov 23. doi: 10.3390/ijms21228870

PMCID:: PMC7700528

Article PubReader PDF–2.4M Cite

Select item 76644372.

Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease

Serena Silvestro, Giovanni Schepici, Placido Bramanti, Emanuela Mazzon

Molecules. 2020 Nov; 25(21): 5186. Published online 2020 Nov 7. doi: 10.3390/molecules25215186

PMCID:: PMC7664437

Article PubReader PDF–911K Cite

Select item 48519253.

Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis

D.C. Hammell, L.P. Zhang, F. Ma, S.M. Abshire, S.L. McIlwrath, A.L. Stinchcomb, K.N. Westlund

Eur J Pain. Author manuscript; available in PMC 2016 Jul 1.

Published in final edited form as: Eur J Pain. 2016 Jul; 20(6): 936–948. Published online 2015 Oct 30. doi: 10.1002/ejp.818

PMCID:: PMC4851925

Article PubReader PDF–800K Cite

Select item 90286074.

The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products

Jinpeng Li, Ricardo Carvajal, Leon Bruner, Norbert E. Kaminski

Food Chem Toxicol. Author manuscript; available in PMC 2022 Nov 1.

Published in final edited form as: Food Chem Toxicol. 2021 Nov; 157: 112600. Published online 2021 Oct 6. doi: 10.1016/j.fct.2021.112600

PMCID:: PMC9028607

Article PubReader PDF–420K Cite

Select item 93199525.

Anti-Inflammatory and Analgesic Properties of the Cannabis Terpene Myrcene in Rat Adjuvant Monoarthritis

Jason J. McDougall, Meagan K. McKenna

Int J Mol Sci. 2022 Jul; 23(14): 7891. Published online 2022 Jul 17. doi: 10.3390/ijms23147891

PMCID:: PMC9319952

Article PubReader PDF–2.0M Cite

Select item 86702906.

Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis

Christopher J Failing, Kevin F. Boehnke, Meredith Riebschleger

Pediatr Rheumatol Online J. 2021; 19: 171. Published online 2021 Dec 13. doi: 10.1186/s12969-021-00656-5

PMCID:: PMC8670290

Article PubReader PDF–1.2M Cite

Select item 99827277.

Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II)

Markus Dieterle, Laura Zurbriggen, Eckhard Mauermann, Katja Mercer-Chalmers-Bender, Priska Frei, Wilhelm Ruppen, Tobias Schneider

Pain. 2022 Oct; 163(10): 1919–1928. Published online 2022 Jan 24. doi: 10.1097/j.pain.0000000000002591

PMCID:: PMC9982727

Article PubReader PDF–756K Cite

Select item 76660698.

The Essential Medicinal Chemistry of Cannabidiol (CBD)

Kathryn M. Nelson, Jonathan Bisson, Gurpreet Singh, James G. Graham, Shao-Nong Chen, J. Brent Friesen, Jayme L. Dahlin, Matthias Niemitz, Michael A. Walters, Guido F. Pauli

J Med Chem. Author manuscript; available in PMC 2021 Nov 12.

Published in final edited form as: J Med Chem. 2020 Nov 12; 63(21): 12137–12155. Published online 2020 Sep 10. doi: 10.1021/acs.jmedchem.0c00724

PMCID:: PMC7666069

Article PubReader PDF–1.6M Cite

Select item 80714219.

Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies

Fei Wang, Gabriele Multhoff

Biomolecules. 2021 Apr; 11(4): 582. Published online 2021 Apr 15. doi: 10.3390/biom11040582

Correction in:: Biomolecules. 2023 Feb; 13(2): 225.

PMCID:: PMC8071421

Article PubReader PDF–1.3M Cite

Select item 656144910.

Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study

Oliver Hendricks, Tonny Elmose Andersen, Afshin Ashouri Christiansen, Jette Primdahl, Ellen Margrethe Hauge, Torkell Ellingsen, Tina Ingrid Horsted, Anja Godske Bachmann, Anne Gitte Loft, Anders Bo Bojesen, Mikkel Østergaard, Merete Lund Hetland, Niels Steen Krogh, Kirsten Kaya Roessler, Kim Hørslev Petersen

BMJ Open. 2019; 9(6): e028197. Published online 2019 Jun 4. doi: 10.1136/bmjopen-2018-028197

PMCID:: PMC6561449

Article PubReader PDF–1.7M Cite

Select item 569029211.

Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis

Holly T. Philpott, Melissa O'Brien, Jason J. McDougall

Pain. 2017 Dec; 158(12): 2442–2451. Published online 2017 Sep 1. doi: 10.1097/j.pain.0000000000001052

PMCID:: PMC5690292

Article PubReader PDF–708K Cite

Select item 746300012.

Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts

Torsten Lowin, Ren Tingting, Julia Zurmahr, Tim Classen, Matthias Schneider, Georg Pongratz

Cell Death Dis. 2020 Aug; 11(8): 714. Published online 2020 Sep 1. doi: 10.1038/s41419-020-02892-1

PMCID:: PMC7463000

Article PubReader PDF–2.1M Cite

Select item 724693613.

Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?

Vicente Martínez, Amaia Iriondo De-Hond, Francesca Borrelli, Raffaele Capasso, María Dolores del Castillo, Raquel Abalo

Int J Mol Sci. 2020 May; 21(9): 3067. Published online 2020 Apr 26. doi: 10.3390/ijms21093067

PMCID:: PMC7246936

Article PubReader PDF–2.7M Cite

Select item 906262814.

Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)

Kevin F. Boehnke, Winfried Häuser, Mary-Ann Fitzcharles

Curr Rheumatol Rep. 2022; 24(7): 238–246. Published online 2022 May 3. doi: 10.1007/s11926-022-01077-3

PMCID:: PMC9062628

Article PubReader PDF–605K Cite

Select item 308554215.

Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress

George W. Booz

Free Radic Biol Med. Author manuscript; available in PMC 2012 Sep 1.

Published in final edited form as: Free Radic Biol Med. 2011 Sep 1; 51(5): 1054–1061. Published online 2011 Jan 14. doi: 10.1016/j.freeradbiomed.2011.01.007

PMCID:: PMC3085542

Article PubReader PDF–1.2M Cite

Select item 1690416.

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

A. M. Malfait, R. Gallily, P. F. Sumariwalla, A. S. Malik, E. Andreakos, R. Mechoulam, M. Feldmann

Proc Natl Acad Sci U S A. 2000 Aug 15; 97(17): 9561–9566. Published online 2000 Aug 1. doi: 10.1073/pnas.160105897

PMCID:: PMC16904

Article PubReader PDF–116K Cite

Select item 965450617.

Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges

Ryan Green, Roukiah Khalil, Shyam S. Mohapatra, Subhra Mohapatra

Int J Mol Sci. 2022 Nov; 23(21): 12956. Published online 2022 Oct 26. doi: 10.3390/ijms232112956

PMCID:: PMC9654506

Article PubReader PDF–3.9M Cite

Select item 692875718.

Cannabidiol—from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer

Brigitta Kis, Feng Chen Ifrim, Valentina Buda, Stefana Avram, Ioana Zinuca Pavel, Diana Antal, Virgil Paunescu, Cristina Adriana Dehelean, Florina Ardelean, Zorita Diaconeasa, Codruta Soica, Corina Danciu

Int J Mol Sci. 2019 Dec; 20(23): 5905. Published online 2019 Nov 25. doi: 10.3390/ijms20235905

PMCID:: PMC6928757

Article PubReader PDF–1.0M Cite

Select item 457666619.

HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid

Christeene G. Haj, Percy F. Sumariwalla, Lumír Hanuš, Natalya M. Kogan, Zhana Yektin, Raphael Mechoulam, Mark Feldmann, Ruth Gallily

J Pharmacol Exp Ther. 2015 Oct; 355(1): 66–75. Published online 2015 Oct. doi: 10.1124/jpet.115.226100

PMCID:: PMC4576666

Article PubReader PDF–1.4M Cite

Select item 800102020.

Cannabidiol and Other Cannabinoids in Demyelinating Diseases

Carmen Navarrete, Adela García-Martín, Alain Rolland, Jim DeMesa, Eduardo Muñoz

Int J Mol Sci. 2021 Mar; 22(6): 2992. Published online 2021 Mar 15. doi: 10.3390/ijms22062992

PMCID:: PMC8001020

Article PubReader PDF–719K Cite

<< First< Prev

Page of 99

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for Arthritis cannabidiol

Figure 2

Presents the treatment flowchart. CBD, cannabidiol; THC, tetrahydrocannabinol.

Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study

BMJ Open. 2019;9(6):e028197.
Fig. 2

Parent/gaurdian perceptions of those using CBD for their child’s arthritis and those contemplating use of CBD (n=89) on how they percieve CBD will help their child’s arthritis (A), how they learned about CBD (B), perception of safety fo CBD (C). 56 respondents haven’t told their child’s rheumatologist for the following reasons (D)

Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis

Pediatr Rheumatol Online J. 2021;19:171.
Figure 4

Quantification of pro-inflammatory biomarkers in the lumbar spinal cord and dorsal root ganglia (DRG). Increases in spinal cord (A) CGRP and (B) OX42 and (C) DRG TNFα after adjuvant-induced monoarthritis are reduced to baseline levels by high doses of transdermal cannabidiol. (n = 4–6 animals per group) (*p < 0.05; one-way ANOVA).

Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis

Eur J Pain. ;20(6):936-948.
Figure 3

Immunocytochemical localization of inflammatory biomarkers. (A) CGRP and (B) OX42 are shown in ipsilateral spinal cord dorsal horn for naïve, complete Freud’s adjuvant (CFA) arthritic and cannabidiol (CBD) treated CFA arthritic rats. (C) TNFα is shown in the ipsilateral dorsal root ganglia of naïve, CFA arthritic and CBD treated CFA arthritic rats. Bar = 100 μm.

Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis

Eur J Pain. ;20(6):936-948.